文献速递运动医学关节外科

脱细胞半月板细胞外基质的区域特异性效应对间充质干细胞基半月板组织工程的影响

Region-Specific Effect of the Decellularized Meniscus Extracellular Matrix on Mesenchymal Stem Cell-Based Meniscus Tissue Engineering.
PubMed 文献 · Am J Sports Med · 2016-12-13

本研究为控制实验室研究,比较内侧与外侧半月板来源脱细胞细胞外基质(mECM)对三维培养人骨髓间充质干细胞(hBMSCs)的影响。结果显示内侧mECM促进纤维软骨分化,外侧mECM促进成纤维细胞表型,支持区域特异性mECM用于半月板组织工程的可行性。

要点

  • 内侧mECM组Ⅱ型胶原和聚集蛋白聚糖表达最高,外侧mECM组Ⅰ型胶原表达显著更高。
  • 外侧mECM组羟脯氨酸含量最高,内、外侧mECM组糖胺聚糖含量均高于无ECM对照组。
  • 结果支持使用区域特异性mECM制备生物活性支架用于半月板组织工程的可行性。

核心结论

  • 内侧mECM增强hBMSCs的纤维软骨分化,而外侧mECM促进更成纤维细胞样的表型。
  • 研究结果支持使用区域特异性mECM制备生物活性支架用于半月板组织工程的可行性。

研究设计与样本

  • 控制实验室研究,将牛半月板分为内、外两半,经Triton X-100和DNase处理及尿素提取制备mECM。
  • 将hBMSCs(1×10^6个/mL)封装于光交联10%聚乙二醇二丙烯酸酯支架中,支架含内侧或外侧mECM(60 μg/mL),以无ECM支架为对照。
  • 细胞接种构建体在含重组人转化生长因子β3(TGF-β3)的软骨培养基中培养,随时间分析半月板相关基因表达及胶原(羟脯氨酸)和糖胺聚糖含量。

主要发现

  • 脱细胞化通过无4',6-二脒基-2-苯基吲哚(DAPI)染色的细胞核和DNA含量降低得到验证。
  • 实时定量聚合酶链反应显示,外侧mECM组Ⅰ型胶原表达显著高于其他组,而内侧mECM组Ⅱ型胶原和聚集蛋白聚糖表达最高。
  • 外侧mECM组胶原(羟脯氨酸)含量最高,而内侧和外侧mECM组糖胺聚糖含量均高于对照组。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The meniscus is the most commonly injured knee structure, and surgical repair is often ineffective. Tissue engineering-based repair or regeneration may provide a needed solution. Decellularized, tissue-derived extracellular matrices (ECMs) have received attention for their potential use as tissue-engineered scaffolds. In considering meniscus-derived ECMs (mECMs) for meniscus tissue engineering, it is noteworthy that the inner and outer regions of the meniscus have different structural and biochemical features, potentially directing the differentiation of cells toward region-specific phenotypes. PURPOSE: To investigate the applicability of mECMs for meniscus tissue engineering by specifically comparing region-dependent effects of mECMs on 3-dimensional constructs seeded with human bone marrow mesenchymal stem cells (hBMSCs). STUDY DESIGN: Controlled laboratory study. METHODS: Bovine menisci were divided into inner and outer halves and were minced, treated with Triton X-100 and DNase, and extracted with urea. Then, hBMSCs (1 × 106 cells/mL) were encapsulated in a photo-cross-linked 10% polyethylene glycol diacrylate scaffold containing mECMs (60 μg/mL) derived from either the inner or outer meniscus, with an ECM-free scaffold as a control. The cell-seeded constructs were cultured with chondrogenic medium containing recombinant human transforming growth factor β3 (TGF-β3) and were analyzed for expression of meniscus-associated genes as well as for the collagen (hydroxyproline) and glycosaminoglycan content as a function of time. RESULTS: Decellularization was verified by the absence of 4',6-diamidino-2-phenylindole (DAPI)-stained cell nuclei and a reduction in the DNA content. Quantitative real-time polymerase chain reaction showed that collagen type I expression was significantly higher in the outer mECM group than in the other groups, while collagen type II and aggrecan expression was highest in the inner mECM group. The collagen (hydroxyproline) content was highest in the outer mECM group, while the glycosaminoglycan content was higher in both the inner and outer mECM groups compared with the control group. CONCLUSION: These results showed that the inner mECM enhances the fibrocartilaginous differentiation of hBMSCs, while the outer mECM promotes a more fibroblastic phenotype. Our findings support the feasibility of fabricating bioactive scaffolds using region-specific mECM preparations for meniscus tissue engineering. CLINICAL RELEVANCE: This is the first report to demonstrate the feasibility of applying region-specific mECMs for the engineering of meniscus implants capable of reproducing the biphasic, anatomic, and biochemical characteristics of the meniscus, features that should contribute to the feasibility of their clinical application.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Shimomura K, Rothrauff BB, Tuan RS, et al. Region-Specific Effect of the Decellularized Meniscus Extracellular Matrix on Mesenchymal Stem Cell-Based Meniscus Tissue Engineering. Am J Sports Med. 2016. PMID: 27895039. doi:10.1177/0363546516674184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。